First Time Loading...

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 110.96 USD 1.53%
Updated: May 3, 2024
JAZZ
/
Income Statement
/
Revenue

Jazz Pharmaceuticals PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Revenue Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Revenue
$3.8B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
16%
Perrigo Company PLC
NYSE:PRGO
Revenue
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Revenue
$28m
CAGR 3-Years
8%
CAGR 5-Years
-23%
CAGR 10-Years
21%
G
GH Research PLC
NASDAQ:GHRS
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Revenue
€96.7m
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
6%
Ovoca Bio PLC
LSE:OVB
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Jazz Pharmaceuticals PLC
Revenue Breakdown

Breakdown by Geography
Jazz Pharmaceuticals PLC

Total Revenue: 3.8B USD
100%
United States: 3.5B USD
91%
Europe: 269.2m USD
7%
Other: 75m USD
2%

Breakdown by Segments
Jazz Pharmaceuticals PLC

Total Revenue: 3.8B USD
100%
Product Sales, Net: 3.7B USD
97.5%
Xywav: 1.3B USD
33.2%
Royalties And Contract Revenues: 97.3m USD
2.5%
High-Sodium Oxybate Ag Royalty Revenue: 75.9m USD
2%
Other Royalty And Contract Revenues: 21.3m USD
0.6%
Show More
Show Less

See Also

What is Jazz Pharmaceuticals PLC's Revenue?
Revenue
3.8B USD

Based on the financial report for Dec 31, 2023, Jazz Pharmaceuticals PLC's Revenue amounts to 3.8B USD.

What is Jazz Pharmaceuticals PLC's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Jazz Pharmaceuticals PLC have been 17% over the past three years , 15% over the past five years , and 16% over the past ten years .

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.